33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Marqués N, Sesé M, Cánovas V, Valente F, Bermudo R, de Torres I, Fernández Y, Abasolo I, Fernández PL, Contreras H, Castellón E, Celià-Terrassa T, Méndez R, Ramón Y Cajal S, Thomson TM, et al. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1. Oncogene. 33: 1124-34. PMID 23455324 DOI: 10.1038/Onc.2013.51  0.38
2012 Celià-Terrassa T, Meca-Cortés O, Mateo F, de Paz AM, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Álvarez-Simón D, Milà J, ... ... Thomson TM, et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. The Journal of Clinical Investigation. 122: 1849-68. PMID 22505459 DOI: 10.1172/Jci59218  0.356
2010 Bermudo R, Abia D, Benitez D, Carrió A, Vilella R, Ortiz AR, Thomson TM, Fernández PL. Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer. Annals of the New York Academy of Sciences. 1210: 17-24. PMID 20973795 DOI: 10.1111/J.1749-6632.2010.05780.X  0.328
2010 Isasa M, Katz EJ, Kim W, Yugo V, González S, Kirkpatrick DS, Thomson TM, Finley D, Gygi SP, Crosas B. Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome. Molecular Cell. 38: 733-45. PMID 20542005 DOI: 10.1016/J.Molcel.2010.05.001  0.31
2010 Gómez V, Sesé M, Santamaría A, Martínez JD, Castellanos E, Soler M, Thomson TM, Paciucci R. Regulation of aurora B kinase by the lipid raft protein flotillin-1. The Journal of Biological Chemistry. 285: 20683-90. PMID 20430883 DOI: 10.1074/Jbc.M110.130591  0.3
2010 Thomson TM, Guerra-Rebollo M. Ubiquitin and SUMO signalling in DNA repair. Biochemical Society Transactions. 38: 116-31. PMID 20074046 DOI: 10.1042/Bst0380116  0.314
2009 Soler M, Mancini F, Meca-Cortés O, Sánchez-Cid L, Rubio N, López-Fernández S, Lozano JJ, Blanco J, Fernández PL, Thomson TM. HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells. International Journal of Cancer. Journal International Du Cancer. 125: 2565-75. PMID 19530240 DOI: 10.1002/Ijc.24651  0.346
2008 Bermudo R, Abia D, Ferrer B, Nayach I, Benguria A, Zaballos A, del Rey J, Miró R, Campo E, Martínez-A C, Ortiz AR, Fernández PL, Thomson TM. Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. Bmc Cancer. 8: 315. PMID 18973659 DOI: 10.1186/1471-2407-8-315  0.339
2008 Plans V, Guerra-Rebollo M, Thomson TM. Regulation of mitotic exit by the RNF8 ubiquitin ligase. Oncogene. 27: 1355-65. PMID 17724460 DOI: 10.1038/Sj.Onc.1210782  0.327
2007 Hurtado M, Lozano JJ, Castellanos E, López-Fernández LA, Harshman K, Martínez-A C, Ortiz AR, Thomson TM, Paciucci R. Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells. Gut. 56: 1266-74. PMID 17452424 DOI: 10.1136/Gut.2006.097188  0.32
2006 Parra G, Reymond A, Dabbouseh N, Dermitzakis ET, Castelo R, Thomson TM, Antonarakis SE, Guigó R. Tandem chimerism as a means to increase protein complexity in the human genome. Genome Research. 16: 37-44. PMID 16344564 DOI: 10.1101/Gr.4145906  0.33
2006 Plans V, Scheper J, Soler M, Loukili N, Okano Y, Thomson TM. The RING finger protein RNF8 recruits UBC13 for lysine 63-based self polyubiquitylation. Journal of Cellular Biochemistry. 97: 572-82. PMID 16215985 DOI: 10.1002/Jcb.20587  0.3
2005 Ferrer B, Bermudo R, Thomson T, Nayach I, Soler M, Sánchez M, Castillo M, Calvo J, Campo E, Fernández PL. Paraffin-embedded cell line microarray (PECLIMA): development and validation of a high-throughput method for antigen profiling of cell lines. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 72: 225-32. PMID 16374066 DOI: 10.1159/000089416  0.311
2005 Lozano JJ, Soler M, Bermudo R, Abia D, Fernandez PL, Thomson TM, Ortiz AR. Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data. Bmc Genomics. 6: 109. PMID 16107210 DOI: 10.1186/1471-2164-6-109  0.307
2005 Santamaría A, Castellanos E, Gómez V, Benedit P, Renau-Piqueras J, Morote J, Reventós J, Thomson TM, Paciucci R. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Molecular and Cellular Biology. 25: 1900-11. PMID 15713644 DOI: 10.1128/Mcb.25.5.1900-1911.2005  0.356
2004 Planagumà J, Díaz-Fuertes M, Gil-Moreno A, Abal M, Monge M, García A, Baró T, Thomson TM, Xercavins J, Alameda F, Reventós J. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Research. 64: 8846-53. PMID 15604243 DOI: 10.1158/0008-5472.Can-04-2066  0.322
2003 Santamaría A, Fernández PL, Farré X, Benedit P, Reventós J, Morote J, Paciucci R, Thomson TM. PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. The American Journal of Pathology. 162: 897-905. PMID 12598323 DOI: 10.1016/S0002-9440(10)63885-0  0.397
2003 Santamaria A, Fernandez P, Farre X, Benedit P, Morote J, Reventos J, Thomson T, Paciucci R. Cell-cycle dependent subcellular distribution and mitogenic effects of PTOV1, a novel protein overexpressed in prostate cancer European Urology Supplements. 2: 161. DOI: 10.1016/S1569-9056(03)80638-3  0.355
2002 Cuenca-Leon E, Cormand B, Thomson T, Macaya A. Paroxysmal kinesigenic dyskinesia and generalized seizures: clinical and genetic analysis in a Spanish pedigree. Neuropediatrics. 33: 288-93. PMID 12571782 DOI: 10.1055/S-2002-37079  0.471
2002 González-Lamuño D, Loukili N, García-Fuentes M, Thomson TM. Expression and regulation of the transcriptional repressor ZNF43 in Ewing sarcoma cells. Pediatric Pathology & Molecular Medicine. 21: 531-40. PMID 12537770 DOI: 10.1080/15227950290112789  0.358
2002 Díaz VM, Planaguma J, Thomson TM, Reventós J, Paciucci R. Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells. Gastroenterology. 122: 806-19. PMID 11875015 DOI: 10.1053/Gast.2002.31885  0.313
2001 Benedit P, Paciucci R, Thomson TM, Valeri M, Nadal M, Càceres C, de Torres I, Estivill X, Lozano JJ, Morote J, Reventós J. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks. Oncogene. 20: 1455-64. PMID 11313889 DOI: 10.1038/Sj.Onc.1204233  0.367
2000 Thomson TM, Lozano JJ, Loukili N, Carrió R, Serras F, Cormand B, Valeri M, Díaz VM, Abril J, Burset M, Merino J, Macaya A, Corominas M, Guigó R. Fusion of the human gene for the polyubiquitination coeffector UEV1 with Kua, a newly identified gene. Genome Research. 10: 1743-56. PMID 11076860 DOI: 10.1101/Gr.Gr-1405R  0.557
1998 Thomson TM, Khalid H, Lozano JJ, Sancho E, Ariño J. Role of UEV-1A, a homologue of the tumor suppressor protein TSG101, in protection from DNA damage Febs Letters. 423: 49-52. PMID 9580084 DOI: 10.1016/S0014-5793(98)00060-X  0.361
1998 Sancho E, Vilá MR, Sánchez-Pulido L, Lozano JJ, Paciucci R, Nadal M, Fox M, Harvey C, Bercovich B, Loukili N, Ciechanover A, Lin SL, Sanz F, Estivill X, Valencia A, ... Thomson TM, et al. Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells Molecular and Cellular Biology. 18: 576-589. PMID 9418904 DOI: 10.1128/Mcb.18.1.576  0.394
1988 Thomson TM, Real FX, Murakami S, Cordon-Cardo C, Old LJ, Houghton AN. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. The Journal of Investigative Dermatology. 90: 459-66. PMID 3280698 DOI: 10.1111/1523-1747.Ep12460906  0.331
1988 Thomson TM, Rettig WJ, Chesa PG, Green SH, Mena AC, Old LJ. Expression of human nerve growth factor receptor on cells derived from all three germ layers. Experimental Cell Research. 174: 533-9. PMID 2828087 DOI: 10.1016/0014-4827(88)90323-0  0.33
1986 Cote RJ, Morrissey DM, Houghton AN, Thomson TM, Daly ME, Oettgen HF, Old LJ. Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens. Proceedings of the National Academy of Sciences of the United States of America. 83: 2959-63. PMID 3458255 DOI: 10.1073/Pnas.83.9.2959  0.347
1986 Rettig WJ, Thomson TM, Spengler BA, Biedler JL, Old LJ. Assignment of human nerve growth factor receptor gene to chromosome 17 and regulation of receptor expression in somatic cell hybrids. Somatic Cell and Molecular Genetics. 12: 441-7. PMID 3020711 DOI: 10.1007/Bf01539915  0.346
1985 Thomson TM, Mattes MJ, Roux L, Old LJ, Lloyd KO. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody Journal of Investigative Dermatology. 85: 169-174. PMID 3926906 DOI: 10.1111/1523-1747.Ep12276608  0.321
1984 Fradet Y, Cordon-Cardo C, Thomson T, Daly ME, Whitmore WF, Lloyd KO, Melamed MR, Old LJ. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America. 81: 224-8. PMID 6364135 DOI: 10.1073/Pnas.81.1.224  0.326
1984 Houghton AN, Thomson TM, Gross D, Oettgen HF, Old LJ. Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon. The Journal of Experimental Medicine. 160: 255-69. PMID 6204001 DOI: 10.1084/Jem.160.1.255  0.301
1983 Mattes MJ, Thomson TM, Old LJ, Lloyd KO. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. International Journal of Cancer. 32: 717-721. PMID 6197381 DOI: 10.1002/Ijc.2910320610  0.308
Show low-probability matches.